Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
by ruth on July 27, 2006

According to a New York Times article, GlaxoSmithKline will seek regulatory approval from the FDA this year, and if approved, the avian flu vaccine will sell for the same price as a standard flu shot, i.e., $8 to $12 a shot.
Read the full story here.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/30406
Mr Wong
Vote for Stronger Avian Flu Vaccine From GlaxoSmithKline:
|
Rating: 6.00 out of 1 vote(s) cast.
|
Response from:
Trusted.MD Network
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







